Publication: Ki-67 and p16 Immunostaining Differentiates Pagetoid Bowen Disease from "microclonal" Seborrheic Keratosis
Issued Date
2019-01-01
Resource Type
ISSN
19437722
00029173
00029173
Other identifier(s)
2-s2.0-85065669458
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
American Journal of Clinical Pathology. Vol.151, No.6 (2019), 551-560
Suggested Citation
Eman Bahrani, Panitta Sitthinamsuwan, Timothy H. McCalmont, Laura B. Pincus Ki-67 and p16 Immunostaining Differentiates Pagetoid Bowen Disease from "microclonal" Seborrheic Keratosis. American Journal of Clinical Pathology. Vol.151, No.6 (2019), 551-560. doi:10.1093/ajcp/aqz001 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/52264
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Ki-67 and p16 Immunostaining Differentiates Pagetoid Bowen Disease from "microclonal" Seborrheic Keratosis
Abstract
© 2019 American Society for Clinical Pathology. All rights reserved. Objectives: We observed keratoses with "clonal" nests present as numerous tiny collections, in which cells in "pagetoid" array are found, a configuration we termed microclonal seborrheic keratosis (MSK). To better distinguish MSK from pagetoid Bowen disease (PBD), we investigated use of immunohistochemical staining. Methods: Biopsy specimens of 26 MSKs, 17 PBDs, and 11 borderline cases were reviewed for histopathology and stained with p53, Ki-67, and p16. Results: High expression of Ki-67 and p16 was observed in 12 (80%) of 15 PBDs and in one (4%) of 23 MSKs. Low expression of p16 and high expression of Ki-67 were observed in 16 (70%) of 23 MSKs and in two (13%) of 15 PBDs. Expression of p16 was elevated in 12 (80%) of 15 PBDs and in three (13%) of 23 MSKs (P <. 0001). Conclusions: We describe a "microclonal" variant of seborrheic keratosis with morphology sometimes challenging to distinguish from PBD. High expression of p16 and Ki-67 or p16 alone favors the diagnosis of PBD over MSK.